Overview

Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Tolerability, undertstanding of the action of the drug in the body, and understanding the effect of the drug in adolescent patients needing treatment with an antipsychotic medication
Phase:
Phase 1
Details
Lead Sponsor:
Vanda Pharmaceuticals
Treatments:
Iloperidone